SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-22-195133
Filing Date
2022-07-15
Accepted
2022-07-15 17:17:10
Documents
19
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d371110d10ka.htm   iXBRL 10-K/A 1022193
2 EX-23.1 d371110dex231.htm EX-23.1 1454
3 EX-31.1 d371110dex311.htm EX-31.1 11488
4 EX-31.2 d371110dex312.htm EX-31.2 11484
5 EX-32.1 d371110dex321.htm EX-32.1 4134
6 EX-32.2 d371110dex322.htm EX-32.2 4130
  Complete submission text file 0001193125-22-195133.txt   1411224

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA celu-20211231.xsd EX-101.SCH 4654
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE celu-20211231_cal.xml EX-101.CAL 656
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE celu-20211231_def.xml EX-101.DEF 19553
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE celu-20211231_lab.xml EX-101.LAB 24855
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE celu-20211231_pre.xml EX-101.PRE 20850
13 EXTRACTED XBRL INSTANCE DOCUMENT d371110d10ka_htm.xml XML 9458
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38914 | Film No.: 221087597
SIC: 2834 Pharmaceutical Preparations